Anupam Dalal - Net Worth and Insider Trading

Anupam Dalal Net Worth

The estimated net worth of Anupam Dalal is at least $3 Million dollars as of 2024-06-07. Anupam Dalal is the Director of Aadi Bioscience Inc and owns about 1,530,532 shares of Aadi Bioscience Inc (AADI) stock worth over $3 Million. Details can be seen in Anupam Dalal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anupam Dalal has not made any transactions after 2021-08-26 and currently still holds the listed stock(s).

Transaction Summary of Anupam Dalal

To

Anupam Dalal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anupam Dalal owns 4 companies in total, including Aerpio Pharmaceuticals Inc (ARPO) , Akebia Therapeutics Inc (AKBA) , and Neos Therapeutics Inc (NEOS) among others .

Click here to see the complete history of Anupam Dalal’s form 4 insider trades.

Insider Ownership Summary of Anupam Dalal

Ticker Comapny Transaction Date Type of Owner
ARPO Aerpio Pharmaceuticals Inc 2020-06-24 director
AKBA Akebia Therapeutics Inc 2014-03-19 director
NEOS Neos Therapeutics Inc 2015-07-28 10 percent owner
LIMIT LIMIT 2021-08-26 director

Anupam Dalal Latest Holdings Summary

Anupam Dalal currently owns a total of 1 stock. Anupam Dalal owns 1,530,532 shares of Aadi Bioscience Inc (AADI) as of August 26, 2021, with a value of $3 Million.

Latest Holdings of Anupam Dalal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AADI Aadi Bioscience Inc 2021-08-26 1,530,532 1.77 2,709,042

Holding Weightings of Anupam Dalal


Anupam Dalal Form 4 Trading Tracker

According to the SEC Form 4 filings, Anupam Dalal has made a total of 2 transactions in Aadi Bioscience Inc (AADI) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aadi Bioscience Inc is the acquisition of 1,529,402 shares on August 26, 2021, which cost Anupam Dalal around $20 Million.

Insider Trading History of Anupam Dalal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anupam Dalal Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anupam Dalal Ownership Network

Ownership Network List of Anupam Dalal

No Data

Ownership Network Relation of Anupam Dalal

Insider Network Chart

Anupam Dalal Owned Company Details

What does Aerpio Pharmaceuticals Inc do?

Who are the key executives at Aerpio Pharmaceuticals Inc?

Anupam Dalal is the director of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .

Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aerpio Pharmaceuticals Inc Insider Transactions

No Available Data

Anupam Dalal Mailing Address

Above is the net worth, insider trading, and ownership report for Anupam Dalal. You might contact Anupam Dalal via mailing address: 88 Kearny Street, Suite 1800, San Francisco Ca 94108.

Discussions on Anupam Dalal

No discussions yet.